Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

The integration of artificial intelligence into in vitro diagnostics is transforming the healthcare landscape with rapid advancements and growing demand. As technology continues to evolve, this market is set to experience significant expansion, driven by innovations that enhance diagnostic accuracy and personalized patient care. Let’s explore the current market size, key growth factors, emerging trends, top players, and regional insights shaping this dynamic sector.

Steady Growth and Market Size Projections for AI in In Vitro Diagnostics

The artificial intelligence in in vitro diagnostics market has seen impressive growth in recent years. It is projected to rise from $3.04 billion in 2025 to $3.6 billion in 2026, marking a compound annual growth rate (CAGR) of 18.4%. This growth during the historical period has been fueled by heightened demand for precise diagnostic tools, expanding laboratory infrastructure, the increasing burden of chronic diseases, the adoption of digital diagnostic technologies, and progress in biomarker research.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28120&type=smp

Looking further ahead, the market is expected to surge to $7.01 billion by 2030, with a compound annual growth rate of 18.1%. Key factors driving this expansion include the growth of cloud-based diagnostic platforms, deeper integration of AI with genomics, the development of point-of-care AI diagnostics, rising investments in personalized medicine, and the growing need for faster and more affordable testing solutions. Among the trends shaping the future of this market are AI-powered laboratory automation, predictive diagnostics for diseases, data-driven interpretation of tests, cloud-based platforms, and personalized patient profiling.

Personalized Medicine as a Catalyst for AI in In Vitro Diagnostics Growth

One of the foremost factors propelling the AI in in vitro diagnostics market is the increasing emphasis on personalized medicine. This healthcare approach customizes prevention, diagnosis, and treatment based on an individual’s genetic makeup, lifestyle, and environment. Advances in genomic sequencing and data analytics are enabling more precise and targeted therapies tailored to individual patients, which in turn demand sophisticated diagnostic tools powered by AI.

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-in-vitro-diagnostics-ivd-global-market-report

Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Global Footprint: Which Region Holds Market Leadership?

Artificial intelligence plays a crucial role by analyzing complex diagnostic data to uncover patient-specific disease patterns, enabling timely and accurate treatment decisions. For example, in February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized treatments for rare diseases in 2023, a significant rise from six approvals in 2022. These new treatments include seven cancer drugs and three for other conditions, highlighting the growing reliance on personalized approaches that are driving demand for AI-enhanced diagnostics.

Segment Breakdown Highlighting Rapidly Expanding Categories in the AI in In Vitro Diagnostics Market

This market is segmented by component, technology, deployment model, application, and end user to provide a comprehensive view of its scope. Components include software, hardware, and services, while technologies involve machine learning, natural language processing, computer vision, robotic process automation, and deep learning. Deployment models range from cloud-based and on-premise to hybrid solutions.

Applications cover diagnostic imaging, laboratory testing, pathology, genomics, and personalized medicine. End users consist of hospitals and clinics, diagnostic laboratories, research institutes, pharmaceutical companies, and medical device manufacturers. Further subcategories include software types such as diagnostic algorithms, data analytics platforms, and decision support systems; hardware like laboratory instruments, imaging devices, and point-of-care devices; and services including consulting, implementation, maintenance, support, training, and education.

Innovative Industry Trends Enhancing Market Growth for AI in In Vitro Diagnostics

Leading companies in this space are focusing on creating advanced AI solutions that improve diagnostic accuracy and streamline clinical workflows. A notable development is the emergence of CE-IVDR-certified transparent AI platforms, which comply with EU regulations while offering clear and auditable decision-making processes to build clinical trust and ensure compliance.

For instance, in May 2025, Diagnostics.ai, a UK-based company, introduced PCR.AI, a smart tool designed to accelerate and improve the accuracy of PCR diagnostics. This platform automates real-time interpretation with over 99.9% accuracy and provides transparency on how results are generated, enhancing laboratory efficiency and regulatory adherence in molecular diagnostics.

Top Companies Driving Innovation and Competition in the AI in In Vitro Diagnostics Market

Several key players dominate the artificial intelligence in in vitro diagnostics market, including Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Sysmex Corporation, QIAGEN N.V., Tempus Labs Inc., BillionToOne Inc., PathAI Inc., Proscia Inc., Indica Labs Inc., Visiopharm A/S, aetherAI Co. Ltd., Ibex Medical Analytics Ltd., Mindpeak GmbH, OncoHost Ltd., Qritive, and Aiforia Technologies Oyj. These companies are leading efforts to advance AI technologies and expand their application across diagnostic fields.

Regional Market Leadership and Growth Prospects in AI for In Vitro Diagnostics

In 2025, North America held the largest share of the artificial intelligence in in vitro diagnostics market, reflecting strong adoption and infrastructure. Meanwhile, the Asia-Pacific region is anticipated to be the fastest-growing market over the forecast period, driven by expanding healthcare systems and increasing investments. Other regions analyzed include South East Asia, Western and Eastern Europe, South America, the Middle East, and Africa, providing a global perspective on market trends and opportunities.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model